The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Microbiome Sequencing Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Human Microbiome Sequencing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Human Microbiome Sequencing market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Genome Analysis accounting for % of the Human Microbiome Sequencing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Next-Generation Sequencing segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Human Microbiome Sequencing include Baseclear B.V., Beijing Genomics Institute (BGI) Genomics Co., Ltd, Charles River Laboratories International Inc., Clinical Microbiomics A/S, and Eurofins Scientific SE, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Human Microbiome Sequencing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Next-Generation Sequencing
Traditional Sequencing Technologies
Other
Market segment by Application, can be divided into
Genome Analysis
Metabolome Analysis
Transcriptome Analysis
Other Omics Analysis
Market segment by players, this report covers
Baseclear B.V.
Beijing Genomics Institute (BGI) Genomics Co., Ltd
Charles River Laboratories International Inc.
Clinical Microbiomics A/S
Eurofins Scientific SE
GENEWIZ, Inc.
Illumina, Inc.
Novogene Corporation
OraSure Technologies, Inc.
Oxford Nanopore Technologies, Inc.
Pacific Biosciences of California, Inc.
QIAGEN N.V.
Second Genome, Inc.
Thermo Fisher Scientific Inc.
Viome, Inc.
CosmosID
Leucine Rich Bio Pvt. Ltd.
Microba
Microbiome Insights Inc.
Molzym GmbH & Co. KG
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Human Microbiome Sequencing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Human Microbiome Sequencing, with revenue, gross margin and global market share of Human Microbiome Sequencing from 2019 to 2022.
Chapter 3, the Human Microbiome Sequencing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Human Microbiome Sequencing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Human Microbiome Sequencing research findings and conclusion, appendix and data source.
Geographical Area
Global
The Human Microbiome Sequencing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Human Microbiome Sequencing market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Genome Analysis accounting for % of the Human Microbiome Sequencing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Next-Generation Sequencing segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Human Microbiome Sequencing include Baseclear B.V., Beijing Genomics Institute (BGI) Genomics Co., Ltd, Charles River Laboratories International Inc., Clinical Microbiomics A/S, and Eurofins Scientific SE, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Human Microbiome Sequencing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Next-Generation Sequencing
Traditional Sequencing Technologies
Other
Market segment by Application, can be divided into
Genome Analysis
Metabolome Analysis
Transcriptome Analysis
Other Omics Analysis
Market segment by players, this report covers
Baseclear B.V.
Beijing Genomics Institute (BGI) Genomics Co., Ltd
Charles River Laboratories International Inc.
Clinical Microbiomics A/S
Eurofins Scientific SE
GENEWIZ, Inc.
Illumina, Inc.
Novogene Corporation
OraSure Technologies, Inc.
Oxford Nanopore Technologies, Inc.
Pacific Biosciences of California, Inc.
QIAGEN N.V.
Second Genome, Inc.
Thermo Fisher Scientific Inc.
Viome, Inc.
CosmosID
Leucine Rich Bio Pvt. Ltd.
Microba
Microbiome Insights Inc.
Molzym GmbH & Co. KG
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Human Microbiome Sequencing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Human Microbiome Sequencing, with revenue, gross margin and global market share of Human Microbiome Sequencing from 2019 to 2022.
Chapter 3, the Human Microbiome Sequencing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Human Microbiome Sequencing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Human Microbiome Sequencing research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Human Microbiome Sequencing
1.2 Classification of Human Microbiome Sequencing by Type
1.2.1 Overview: Global Human Microbiome Sequencing Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Human Microbiome Sequencing Revenue Market Share by Type in 2021
1.2.3 Next-Generation Sequencing
1.2.4 Traditional Sequencing Technologies
1.2.5 Other
1.3 Global Human Microbiome Sequencing Market by Application
1.3.1 Overview: Global Human Microbiome Sequencing Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Genome Analysis
1.3.3 Metabolome Analysis
1.3.4 Transcriptome Analysis
1.3.5 Other Omics Analysis
1.4 Global Human Microbiome Sequencing Market Size & Forecast
1.5 Global Human Microbiome Sequencing Market Size and Forecast by Region
1.5.1 Global Human Microbiome Sequencing Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Human Microbiome Sequencing Market Size by Region, (2017-2022)
1.5.3 North America Human Microbiome Sequencing Market Size and Prospect (2017-2028)
1.5.4 Europe Human Microbiome Sequencing Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Human Microbiome Sequencing Market Size and Prospect (2017-2028)
1.5.6 South America Human Microbiome Sequencing Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Human Microbiome Sequencing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Microbiome Sequencing Market Drivers
1.6.2 Human Microbiome Sequencing Market Restraints
1.6.3 Human Microbiome Sequencing Trends Analysis
2 Company Profiles
2.1 Baseclear B.V.
2.1.1 Baseclear B.V. Details
2.1.2 Baseclear B.V. Major Business
2.1.3 Baseclear B.V. Human Microbiome Sequencing Product and Solutions
2.1.4 Baseclear B.V. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Baseclear B.V. Recent Developments and Future Plans
2.2 Beijing Genomics Institute (BGI) Genomics Co., Ltd
2.2.1 Beijing Genomics Institute (BGI) Genomics Co., Ltd Details
2.2.2 Beijing Genomics Institute (BGI) Genomics Co., Ltd Major Business
2.2.3 Beijing Genomics Institute (BGI) Genomics Co., Ltd Human Microbiome Sequencing Product and Solutions
2.2.4 Beijing Genomics Institute (BGI) Genomics Co., Ltd Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Beijing Genomics Institute (BGI) Genomics Co., Ltd Recent Developments and Future Plans
2.3 Charles River Laboratories International Inc.
2.3.1 Charles River Laboratories International Inc. Details
2.3.2 Charles River Laboratories International Inc. Major Business
2.3.3 Charles River Laboratories International Inc. Human Microbiome Sequencing Product and Solutions
2.3.4 Charles River Laboratories International Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Charles River Laboratories International Inc. Recent Developments and Future Plans
2.4 Clinical Microbiomics A/S
2.4.1 Clinical Microbiomics A/S Details
2.4.2 Clinical Microbiomics A/S Major Business
2.4.3 Clinical Microbiomics A/S Human Microbiome Sequencing Product and Solutions
2.4.4 Clinical Microbiomics A/S Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Clinical Microbiomics A/S Recent Developments and Future Plans
2.5 Eurofins Scientific SE
2.5.1 Eurofins Scientific SE Details
2.5.2 Eurofins Scientific SE Major Business
2.5.3 Eurofins Scientific SE Human Microbiome Sequencing Product and Solutions
2.5.4 Eurofins Scientific SE Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Eurofins Scientific SE Recent Developments and Future Plans
2.6 GENEWIZ, Inc.
2.6.1 GENEWIZ, Inc. Details
2.6.2 GENEWIZ, Inc. Major Business
2.6.3 GENEWIZ, Inc. Human Microbiome Sequencing Product and Solutions
2.6.4 GENEWIZ, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 GENEWIZ, Inc. Recent Developments and Future Plans
2.7 Illumina, Inc.
2.7.1 Illumina, Inc. Details
2.7.2 Illumina, Inc. Major Business
2.7.3 Illumina, Inc. Human Microbiome Sequencing Product and Solutions
2.7.4 Illumina, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Illumina, Inc. Recent Developments and Future Plans
2.8 Novogene Corporation
2.8.1 Novogene Corporation Details
2.8.2 Novogene Corporation Major Business
2.8.3 Novogene Corporation Human Microbiome Sequencing Product and Solutions
2.8.4 Novogene Corporation Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Novogene Corporation Recent Developments and Future Plans
2.9 OraSure Technologies, Inc.
2.9.1 OraSure Technologies, Inc. Details
2.9.2 OraSure Technologies, Inc. Major Business
2.9.3 OraSure Technologies, Inc. Human Microbiome Sequencing Product and Solutions
2.9.4 OraSure Technologies, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 OraSure Technologies, Inc. Recent Developments and Future Plans
2.10 Oxford Nanopore Technologies, Inc.
2.10.1 Oxford Nanopore Technologies, Inc. Details
2.10.2 Oxford Nanopore Technologies, Inc. Major Business
2.10.3 Oxford Nanopore Technologies, Inc. Human Microbiome Sequencing Product and Solutions
2.10.4 Oxford Nanopore Technologies, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Oxford Nanopore Technologies, Inc. Recent Developments and Future Plans
2.11 Pacific Biosciences of California, Inc.
2.11.1 Pacific Biosciences of California, Inc. Details
2.11.2 Pacific Biosciences of California, Inc. Major Business
2.11.3 Pacific Biosciences of California, Inc. Human Microbiome Sequencing Product and Solutions
2.11.4 Pacific Biosciences of California, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Pacific Biosciences of California, Inc. Recent Developments and Future Plans
2.12 QIAGEN N.V.
2.12.1 QIAGEN N.V. Details
2.12.2 QIAGEN N.V. Major Business
2.12.3 QIAGEN N.V. Human Microbiome Sequencing Product and Solutions
2.12.4 QIAGEN N.V. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 QIAGEN N.V. Recent Developments and Future Plans
2.13 Second Genome, Inc.
2.13.1 Second Genome, Inc. Details
2.13.2 Second Genome, Inc. Major Business
2.13.3 Second Genome, Inc. Human Microbiome Sequencing Product and Solutions
2.13.4 Second Genome, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Second Genome, Inc. Recent Developments and Future Plans
2.14 Thermo Fisher Scientific Inc.
2.14.1 Thermo Fisher Scientific Inc. Details
2.14.2 Thermo Fisher Scientific Inc. Major Business
2.14.3 Thermo Fisher Scientific Inc. Human Microbiome Sequencing Product and Solutions
2.14.4 Thermo Fisher Scientific Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
2.15 Viome, Inc.
2.15.1 Viome, Inc. Details
2.15.2 Viome, Inc. Major Business
2.15.3 Viome, Inc. Human Microbiome Sequencing Product and Solutions
2.15.4 Viome, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Viome, Inc. Recent Developments and Future Plans
2.16 CosmosID
2.16.1 CosmosID Details
2.16.2 CosmosID Major Business
2.16.3 CosmosID Human Microbiome Sequencing Product and Solutions
2.16.4 CosmosID Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 CosmosID Recent Developments and Future Plans
2.17 Leucine Rich Bio Pvt. Ltd.
2.17.1 Leucine Rich Bio Pvt. Ltd. Details
2.17.2 Leucine Rich Bio Pvt. Ltd. Major Business
2.17.3 Leucine Rich Bio Pvt. Ltd. Human Microbiome Sequencing Product and Solutions
2.17.4 Leucine Rich Bio Pvt. Ltd. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Leucine Rich Bio Pvt. Ltd. Recent Developments and Future Plans
2.18 Microba
2.18.1 Microba Details
2.18.2 Microba Major Business
2.18.3 Microba Human Microbiome Sequencing Product and Solutions
2.18.4 Microba Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 Microba Recent Developments and Future Plans
2.19 Microbiome Insights Inc.
2.19.1 Microbiome Insights Inc. Details
2.19.2 Microbiome Insights Inc. Major Business
2.19.3 Microbiome Insights Inc. Human Microbiome Sequencing Product and Solutions
2.19.4 Microbiome Insights Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19.5 Microbiome Insights Inc. Recent Developments and Future Plans
2.20 Molzym GmbH & Co. KG
2.20.1 Molzym GmbH & Co. KG Details
2.20.2 Molzym GmbH & Co. KG Major Business
2.20.3 Molzym GmbH & Co. KG Human Microbiome Sequencing Product and Solutions
2.20.4 Molzym GmbH & Co. KG Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20.5 Molzym GmbH & Co. KG Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Human Microbiome Sequencing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Human Microbiome Sequencing Players Market Share in 2021
3.2.2 Top 10 Human Microbiome Sequencing Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Human Microbiome Sequencing Players Head Office, Products and Services Provided
3.4 Human Microbiome Sequencing Mergers & Acquisitions
3.5 Human Microbiome Sequencing New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Human Microbiome Sequencing Revenue and Market Share by Type (2017-2022)
4.2 Global Human Microbiome Sequencing Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Human Microbiome Sequencing Revenue Market Share by Application (2017-2022)
5.2 Global Human Microbiome Sequencing Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Human Microbiome Sequencing Revenue by Type (2017-2028)
6.2 North America Human Microbiome Sequencing Revenue by Application (2017-2028)
6.3 North America Human Microbiome Sequencing Market Size by Country
6.3.1 North America Human Microbiome Sequencing Revenue by Country (2017-2028)
6.3.2 United States Human Microbiome Sequencing Market Size and Forecast (2017-2028)
6.3.3 Canada Human Microbiome Sequencing Market Size and Forecast (2017-2028)
6.3.4 Mexico Human Microbiome Sequencing Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Human Microbiome Sequencing Revenue by Type (2017-2028)
7.2 Europe Human Microbiome Sequencing Revenue by Application (2017-2028)
7.3 Europe Human Microbiome Sequencing Market Size by Country
7.3.1 Europe Human Microbiome Sequencing Revenue by Country (2017-2028)
7.3.2 Germany Human Microbiome Sequencing Market Size and Forecast (2017-2028)
7.3.3 France Human Microbiome Sequencing Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Human Microbiome Sequencing Market Size and Forecast (2017-2028)
7.3.5 Russia Human Microbiome Sequencing Market Size and Forecast (2017-2028)
7.3.6 Italy Human Microbiome Sequencing Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Human Microbiome Sequencing Revenue by Type (2017-2028)
8.2 Asia-Pacific Human Microbiome Sequencing Revenue by Application (2017-2028)
8.3 Asia-Pacific Human Microbiome Sequencing Market Size by Region
8.3.1 Asia-Pacific Human Microbiome Sequencing Revenue by Region (2017-2028)
8.3.2 China Human Microbiome Sequencing Market Size and Forecast (2017-2028)
8.3.3 Japan Human Microbiome Sequencing Market Size and Forecast (2017-2028)
8.3.4 South Korea Human Microbiome Sequencing Market Size and Forecast (2017-2028)
8.3.5 India Human Microbiome Sequencing Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Human Microbiome Sequencing Market Size and Forecast (2017-2028)
8.3.7 Australia Human Microbiome Sequencing Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Human Microbiome Sequencing Revenue by Type (2017-2028)
9.2 South America Human Microbiome Sequencing Revenue by Application (2017-2028)
9.3 South America Human Microbiome Sequencing Market Size by Country
9.3.1 South America Human Microbiome Sequencing Revenue by Country (2017-2028)
9.3.2 Brazil Human Microbiome Sequencing Market Size and Forecast (2017-2028)
9.3.3 Argentina Human Microbiome Sequencing Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Human Microbiome Sequencing Revenue by Type (2017-2028)
10.2 Middle East & Africa Human Microbiome Sequencing Revenue by Application (2017-2028)
10.3 Middle East & Africa Human Microbiome Sequencing Market Size by Country
10.3.1 Middle East & Africa Human Microbiome Sequencing Revenue by Country (2017-2028)
10.3.2 Turkey Human Microbiome Sequencing Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Human Microbiome Sequencing Market Size and Forecast (2017-2028)
10.3.4 UAE Human Microbiome Sequencing Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Human Microbiome Sequencing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Human Microbiome Sequencing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Human Microbiome Sequencing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Human Microbiome Sequencing Revenue (USD Million) by Region (2017-2022)
Table 5. Global Human Microbiome Sequencing Revenue Market Share by Region (2023-2028)
Table 6. Baseclear B.V. Corporate Information, Head Office, and Major Competitors
Table 7. Baseclear B.V. Major Business
Table 8. Baseclear B.V. Human Microbiome Sequencing Product and Solutions
Table 9. Baseclear B.V. Human Microbiome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Beijing Genomics Institute (BGI) Genomics Co., Ltd Corporate Information, Head Office, and Major Competitors
Table 11. Beijing Genomics Institute (BGI) Genomics Co., Ltd Major Business
Table 12. Beijing Genomics Institute (BGI) Genomics Co., Ltd Human Microbiome Sequencing Product and Solutions
Table 13. Beijing Genomics Institute (BGI) Genomics Co., Ltd Human Microbiome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Charles River Laboratories International Inc. Corporate Information, Head Office, and Major Competitors
Table 15. Charles River Laboratories International Inc. Major Business
Table 16. Charles River Laboratories International Inc. Human Microbiome Sequencing Product and Solutions
Table 17. Charles River Laboratories International Inc. Human Microbiome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Clinical Microbiomics A/S Corporate Information, Head Office, and Major Competitors
Table 19. Clinical Microbiomics A/S Major Business
Table 20. Clinical Microbiomics A/S Human Microbiome Sequencing Product and Solutions
Table 21. Clinical Microbiomics A/S Human Microbiome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Eurofins Scientific SE Corporate Information, Head Office, and Major Competitors
Table 23. Eurofins Scientific SE Major Business
Table 24. Eurofins Scientific SE Human Microbiome Sequencing Product and Solutions
Table 25. Eurofins Scientific SE Human Microbiome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. GENEWIZ, Inc. Corporate Information, Head Office, and Major Competitors
Table 27. GENEWIZ, Inc. Major Business
Table 28. GENEWIZ, Inc. Human Microbiome Sequencing Product and Solutions
Table 29. GENEWIZ, Inc. Human Microbiome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Illumina, Inc. Corporate Information, Head Office, and Major Competitors
Table 31. Illumina, Inc. Major Business
Table 32. Illumina, Inc. Human Microbiome Sequencing Product and Solutions
Table 33. Illumina, Inc. Human Microbiome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Novogene Corporation Corporate Information, Head Office, and Major Competitors
Table 35. Novogene Corporation Major Business
Table 36. Novogene Corporation Human Microbiome Sequencing Product and Solutions
Table 37. Novogene Corporation Human Microbiome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. OraSure Technologies, Inc. Corporate Information, Head Office, and Major Competitors
Table 39. OraSure Technologies, Inc. Major Business
Table 40. OraSure Technologies, Inc. Human Microbiome Sequencing Product and Solutions
Table 41. OraSure Technologies, Inc. Human Microbiome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Oxford Nanopore Technologies, Inc. Corporate Information, Head Office, and Major Competitors
Table 43. Oxford Nanopore Technologies, Inc. Major Business
Table 44. Oxford Nanopore Technologies, Inc. Human Microbiome Sequencing Product and Solutions
Table 45. Oxford Nanopore Technologies, Inc. Human Microbiome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Pacific Biosciences of California, Inc. Corporate Information, Head Office, and Major Competitors
Table 47. Pacific Biosciences of California, Inc. Major Business
Table 48. Pacific Biosciences of California, Inc. Human Microbiome Sequencing Product and Solutions
Table 49. Pacific Biosciences of California, Inc. Human Microbiome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. QIAGEN N.V. Corporate Information, Head Office, and Major Competitors
Table 51. QIAGEN N.V. Major Business
Table 52. QIAGEN N.V. Human Microbiome Sequencing Product and Solutions
Table 53. QIAGEN N.V. Human Microbiome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Second Genome, Inc. Corporate Information, Head Office, and Major Competitors
Table 55. Second Genome, Inc. Major Business
Table 56. Second Genome, Inc. Human Microbiome Sequencing Product and Solutions
Table 57. Second Genome, Inc. Human Microbiome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Thermo Fisher Scientific Inc. Corporate Information, Head Office, and Major Competitors
Table 59. Thermo Fisher Scientific Inc. Major Business
Table 60. Thermo Fisher Scientific Inc. Human Microbiome Sequencing Product and Solutions
Table 61. Thermo Fisher Scientific Inc. Human Microbiome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Viome, Inc. Corporate Information, Head Office, and Major Competitors
Table 63. Viome, Inc. Major Business
Table 64. Viome, Inc. Human Microbiome Sequencing Product and Solutions
Table 65. Viome, Inc. Human Microbiome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. CosmosID Corporate Information, Head Office, and Major Competitors
Table 67. CosmosID Major Business
Table 68. CosmosID Human Microbiome Sequencing Product and Solutions
Table 69. CosmosID Human Microbiome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Leucine Rich Bio Pvt. Ltd. Corporate Information, Head Office, and Major Competitors
Table 71. Leucine Rich Bio Pvt. Ltd. Major Business
Table 72. Leucine Rich Bio Pvt. Ltd. Human Microbiome Sequencing Product and Solutions
Table 73. Leucine Rich Bio Pvt. Ltd. Human Microbiome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Microba Corporate Information, Head Office, and Major Competitors
Table 75. Microba Major Business
Table 76. Microba Human Microbiome Sequencing Product and Solutions
Table 77. Microba Human Microbiome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. Microbiome Insights Inc. Corporate Information, Head Office, and Major Competitors
Table 79. Microbiome Insights Inc. Major Business
Table 80. Microbiome Insights Inc. Human Microbiome Sequencing Product and Solutions
Table 81. Microbiome Insights Inc. Human Microbiome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 82. Molzym GmbH & Co. KG Corporate Information, Head Office, and Major Competitors
Table 83. Molzym GmbH & Co. KG Major Business
Table 84. Molzym GmbH & Co. KG Human Microbiome Sequencing Product and Solutions
Table 85. Molzym GmbH & Co. KG Human Microbiome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 86. Global Human Microbiome Sequencing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 87. Global Human Microbiome Sequencing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 88. Breakdown of Human Microbiome Sequencing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 89. Human Microbiome Sequencing Players Head Office, Products and Services Provided
Table 90. Human Microbiome Sequencing Mergers & Acquisitions in the Past Five Years
Table 91. Human Microbiome Sequencing New Entrants and Expansion Plans
Table 92. Global Human Microbiome Sequencing Revenue (USD Million) by Type (2017-2022)
Table 93. Global Human Microbiome Sequencing Revenue Share by Type (2017-2022)
Table 94. Global Human Microbiome Sequencing Revenue Forecast by Type (2023-2028)
Table 95. Global Human Microbiome Sequencing Revenue by Application (2017-2022)
Table 96. Global Human Microbiome Sequencing Revenue Forecast by Application (2023-2028)
Table 97. North America Human Microbiome Sequencing Revenue by Type (2017-2022) & (USD Million)
Table 98. North America Human Microbiome Sequencing Revenue by Type (2023-2028) & (USD Million)
Table 99. North America Human Microbiome Sequencing Revenue by Application (2017-2022) & (USD Million)
Table 100. North America Human Microbiome Sequencing Revenue by Application (2023-2028) & (USD Million)
Table 101. North America Human Microbiome Sequencing Revenue by Country (2017-2022) & (USD Million)
Table 102. North America Human Microbiome Sequencing Revenue by Country (2023-2028) & (USD Million)
Table 103. Europe Human Microbiome Sequencing Revenue by Type (2017-2022) & (USD Million)
Table 104. Europe Human Microbiome Sequencing Revenue by Type (2023-2028) & (USD Million)
Table 105. Europe Human Microbiome Sequencing Revenue by Application (2017-2022) & (USD Million)
Table 106. Europe Human Microbiome Sequencing Revenue by Application (2023-2028) & (USD Million)
Table 107. Europe Human Microbiome Sequencing Revenue by Country (2017-2022) & (USD Million)
Table 108. Europe Human Microbiome Sequencing Revenue by Country (2023-2028) & (USD Million)
Table 109. Asia-Pacific Human Microbiome Sequencing Revenue by Type (2017-2022) & (USD Million)
Table 110. Asia-Pacific Human Microbiome Sequencing Revenue by Type (2023-2028) & (USD Million)
Table 111. Asia-Pacific Human Microbiome Sequencing Revenue by Application (2017-2022) & (USD Million)
Table 112. Asia-Pacific Human Microbiome Sequencing Revenue by Application (2023-2028) & (USD Million)
Table 113. Asia-Pacific Human Microbiome Sequencing Revenue by Region (2017-2022) & (USD Million)
Table 114. Asia-Pacific Human Microbiome Sequencing Revenue by Region (2023-2028) & (USD Million)
Table 115. South America Human Microbiome Sequencing Revenue by Type (2017-2022) & (USD Million)
Table 116. South America Human Microbiome Sequencing Revenue by Type (2023-2028) & (USD Million)
Table 117. South America Human Microbiome Sequencing Revenue by Application (2017-2022) & (USD Million)
Table 118. South America Human Microbiome Sequencing Revenue by Application (2023-2028) & (USD Million)
Table 119. South America Human Microbiome Sequencing Revenue by Country (2017-2022) & (USD Million)
Table 120. South America Human Microbiome Sequencing Revenue by Country (2023-2028) & (USD Million)
Table 121. Middle East & Africa Human Microbiome Sequencing Revenue by Type (2017-2022) & (USD Million)
Table 122. Middle East & Africa Human Microbiome Sequencing Revenue by Type (2023-2028) & (USD Million)
Table 123. Middle East & Africa Human Microbiome Sequencing Revenue by Application (2017-2022) & (USD Million)
Table 124. Middle East & Africa Human Microbiome Sequencing Revenue by Application (2023-2028) & (USD Million)
Table 125. Middle East & Africa Human Microbiome Sequencing Revenue by Country (2017-2022) & (USD Million)
Table 126. Middle East & Africa Human Microbiome Sequencing Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Human Microbiome Sequencing Picture
Figure 2. Global Human Microbiome Sequencing Revenue Market Share by Type in 2021
Figure 3. Next-Generation Sequencing
Figure 4. Traditional Sequencing Technologies
Figure 5. Other
Figure 6. Human Microbiome Sequencing Revenue Market Share by Application in 2021
Figure 7. Genome Analysis Picture
Figure 8. Metabolome Analysis Picture
Figure 9. Transcriptome Analysis Picture
Figure 10. Other Omics Analysis Picture
Figure 11. Global Human Microbiome Sequencing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Human Microbiome Sequencing Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Human Microbiome Sequencing Revenue Market Share by Region (2017-2028)
Figure 14. Global Human Microbiome Sequencing Revenue Market Share by Region in 2021
Figure 15. North America Human Microbiome Sequencing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Human Microbiome Sequencing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Human Microbiome Sequencing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Human Microbiome Sequencing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Human Microbiome Sequencing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Human Microbiome Sequencing Market Drivers
Figure 21. Human Microbiome Sequencing Market Restraints
Figure 22. Human Microbiome Sequencing Market Trends
Figure 23. Baseclear B.V. Recent Developments and Future Plans
Figure 24. Beijing Genomics Institute (BGI) Genomics Co., Ltd Recent Developments and Future Plans
Figure 25. Charles River Laboratories International Inc. Recent Developments and Future Plans
Figure 26. Clinical Microbiomics A/S Recent Developments and Future Plans
Figure 27. Eurofins Scientific SE Recent Developments and Future Plans
Figure 28. GENEWIZ, Inc. Recent Developments and Future Plans
Figure 29. Illumina, Inc. Recent Developments and Future Plans
Figure 30. Novogene Corporation Recent Developments and Future Plans
Figure 31. OraSure Technologies, Inc. Recent Developments and Future Plans
Figure 32. Oxford Nanopore Technologies, Inc. Recent Developments and Future Plans
Figure 33. Pacific Biosciences of California, Inc. Recent Developments and Future Plans
Figure 34. QIAGEN N.V. Recent Developments and Future Plans
Figure 35. Second Genome, Inc. Recent Developments and Future Plans
Figure 36. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
Figure 37. Viome, Inc. Recent Developments and Future Plans
Figure 38. CosmosID Recent Developments and Future Plans
Figure 39. Leucine Rich Bio Pvt. Ltd. Recent Developments and Future Plans
Figure 40. Microba Recent Developments and Future Plans
Figure 41. Microbiome Insights Inc. Recent Developments and Future Plans
Figure 42. Molzym GmbH & Co. KG Recent Developments and Future Plans
Figure 43. Global Human Microbiome Sequencing Revenue Share by Players in 2021
Figure 44. Human Microbiome Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 45. Global Top 3 Players Human Microbiome Sequencing Revenue Market Share in 2021
Figure 46. Global Top 10 Players Human Microbiome Sequencing Revenue Market Share in 2021
Figure 47. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 48. Global Human Microbiome Sequencing Revenue Share by Type in 2021
Figure 49. Global Human Microbiome Sequencing Market Share Forecast by Type (2023-2028)
Figure 50. Global Human Microbiome Sequencing Revenue Share by Application in 2021
Figure 51. Global Human Microbiome Sequencing Market Share Forecast by Application (2023-2028)
Figure 52. North America Human Microbiome Sequencing Sales Market Share by Type (2017-2028)
Figure 53. North America Human Microbiome Sequencing Sales Market Share by Application (2017-2028)
Figure 54. North America Human Microbiome Sequencing Revenue Market Share by Country (2017-2028)
Figure 55. United States Human Microbiome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Canada Human Microbiome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Mexico Human Microbiome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Europe Human Microbiome Sequencing Sales Market Share by Type (2017-2028)
Figure 59. Europe Human Microbiome Sequencing Sales Market Share by Application (2017-2028)
Figure 60. Europe Human Microbiome Sequencing Revenue Market Share by Country (2017-2028)
Figure 61. Germany Human Microbiome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. France Human Microbiome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. United Kingdom Human Microbiome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Russia Human Microbiome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Italy Human Microbiome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Asia-Pacific Human Microbiome Sequencing Sales Market Share by Type (2017-2028)
Figure 67. Asia-Pacific Human Microbiome Sequencing Sales Market Share by Application (2017-2028)
Figure 68. Asia-Pacific Human Microbiome Sequencing Revenue Market Share by Region (2017-2028)
Figure 69. China Human Microbiome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Japan Human Microbiome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. South Korea Human Microbiome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. India Human Microbiome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Southeast Asia Human Microbiome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Australia Human Microbiome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South America Human Microbiome Sequencing Sales Market Share by Type (2017-2028)
Figure 76. South America Human Microbiome Sequencing Sales Market Share by Application (2017-2028)
Figure 77. South America Human Microbiome Sequencing Revenue Market Share by Country (2017-2028)
Figure 78. Brazil Human Microbiome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Argentina Human Microbiome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Middle East and Africa Human Microbiome Sequencing Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Human Microbiome Sequencing Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Human Microbiome Sequencing Revenue Market Share by Country (2017-2028)
Figure 83. Turkey Human Microbiome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. Saudi Arabia Human Microbiome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. UAE Human Microbiome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 86. Methodology
Figure 87. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
